Increased prevalence of allergic sensitisation in rheumatoid arthritis patients treated with anti-TNFα

Joint Bone Spine

Volumn 76, Issue 5, 2009, Pages 508-513

  Machado, Pedro ^a   Santos, Alexandra ^a   Pereira, Celso ^a   Loureiro, Carlos ^a   Silva, Jorge ^a   Chieira, Celso ^a   Malcata, Armando ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Allergy; Atopy; Autoimmunity; Rheumatoid arthritis; TNF

Indexed keywords

ADALIMUMAB; ALLERGEN; C REACTIVE PROTEIN; ETANERCEPT; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; AGE DISTRIBUTION; AGED; ALLERGIC DISEASE; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MALE; PREVALENCE; PRICK TEST; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SENSITIZATION; SEX RATIO; SKIN TEST;

ADULT; ANIMALS; ANTIBODIES; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERSENSITIVITY; MALE; MIDDLE AGED; QUESTIONNAIRES; SKIN TESTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70449521217     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2009.01.007     Document Type: Article

References (41)

1. Breedveld F.C., and Verweij C.L. T cells in rheumatoid arthritis. Br J Rheumatol 36 (1997) 617-619
2. Paul W.E., and Seder R.A. Lymphocyte responses and cytokines. Cell 76 (1994) 241-251
3. Romagnani S. Lymphokine production by human T cells in disease states. Ann Rev Immunol 12 (1994) 227-257
4. Dolhain R.J., van der Heiden A.N., ter Haar N.T., et al. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum 39 (1996) 1961-1969
5. Simon A.K., Seipelt E., and Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 91 (1994) 8562-8566
6. Cohen S.B., Katsikis P.D., Chu C.Q., et al. High level of interleukin-10 production by the activated T cell population within the rheumatoid synovial membrane. Arthritis Rheum 38 (1995) 946-952
7. Vercelli D., Jabara H.H., Lauener R.P., et al. IL-4 inhibits the synthesis of IFN-gamma and induces the synthesis of IgE in human mixed lymphocyte cultures. J Immunol 144 (1990) 570-573
8. Arshad S.H., Tariq S.M., Matthews S., et al. Sensitization to common allergens and its association with allergic disorders at age 4 years: A whole population birth cohort study. Pediatrics 108 (2001) E33
9. Vital E.M., and Emery P. The development of targeted therapies in rheumatoid arthritis. J Autoimmun 31 (2008) 219-227
10. Bazzoni F., and Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med 334 (1996) 1717-1725
11. Aggarwal B.B. Signalling pathways of the TNF superfamily: A double-edged sword. Nat Rev Immunol 3 (2003) 745-756
12. van der Heijde D.M., van't Hof M., van Riel P.L., et al. Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 20 (1993) 579-581
13. Burney P., Potts J., Makowska J., et al. A case-control study of the relation between plasma selenium and asthma in European populations: A GAL2EN project. Allergy 63 (2008) 865-871
14. Heinzerling L., Frew A.J., Bindslev-Jensen C., et al. Standard skin prick testing and sensitization to inhalant allergens across Europe - a survey from the GALEN network. Allergy 60 (2005) 1287-1300
15. Mangge H., Gindl S., Kenzian H., et al. Atopic dermatitis as a side effect of anti-tumor necrosis factor-alpha therapy. J Rheumatol 30 (2003) 2506-2507
16. Chan J.L., Davis-Reed L., and Kimball A.B. Counter-regulatory balance: Atopic dermatitis in patients undergoing infliximab infusion therapy. J Drugs Dermatol 3 (2004) 315-318
17. Vestergaard C., Deleuran M., and Kragballe K. Two cases of atopic dermatitis-like conditions induced in psoriasis patients treated with infliximab. J Eur Acad Dermatol Venereol 21 (2007) 1272-1274
18. Briolay J., Dechanet J., Blanchard D., et al. Interleukin 4 inhibits polyclonal immunoglobulin secretion and cytokine production by peripheral blood mononuclear cells from rheumatoid arthritis patients. J Clin Immunol 12 (1992) 36-44
19. Essner R., Rhoades K., McBride W.H., et al. IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J Immunol 142 (1989) 3857-3861
20. Del Prete G., De Carli M., Almerigogna F., et al. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 150 (1993) 353-360
21. Liblau R.S., Singer S.M., and McDevitt H.O. Th1 and Th2 CD4 + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 16 (1995) 34-38
22. Saoudi A., Kuhn J., Huygen K., et al. Th2 activated cells prevent experimental autoimmune uveoretinitis, a Th1-dependent autoimmune disease. Eur J Immunol 23 (1993) 3096-3103
23. Bessis N., Boissier M.C., Ferrara P., et al. Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13. Eur J Immunol 26 (1996) 2399-2403
24. Cua D.J., Hinton D.R., and Stohlman S.A. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease. J Immunol 155 (1995) 4052-4059
25. Falcone M., and Bloom B.R. A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis. J Exp Med 185 (1997) 901-907
26. O'Driscoll B.R., Milburn H.J., Kemeny D.M., et al. Atopy and rheumatoid arthritis. Clin Allergy 15 (1985) 547-553
27. Hassan W.U., Keaney N.P., Holland C.D., et al. Bronchial reactivity and airflow obstruction in rheumatoid arthritis. Ann Rheum Dis 53 (1994) 511-514
28. Olsson A.R., Wingren G., Skogh T., et al. Allergic manifestations in patients with rheumatoid arthritis. Acta Pathol Microbiol Immunol Scand 111 (2003) 940-944
29. Reckner Olsson A., Skogh T., and Wingren G. Comorbidity and lifestyle, reproductive factors, and environmental exposures associated with rheumatoid arthritis. Ann Rheum Dis 60 (2001) 934-939
30. Hilliquin P., Allanore Y., Coste J., et al. Reduced incidence and prevalence of atopy in rheumatoid arthritis. Results of a case-control study. Rheumatology (Oxford) 39 (2000) 1020-1026
31. Rudwaleit M., Andermann B., Alten R., et al. Atopic disorders in ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis 61 (2002) 968-974
32. Verhoef C.M., van Roon J.A., Vianen M.E., et al. Mutual antagonism of rheumatoid arthritis and hay fever; a role for type 1/type 2 T cell balance. Ann Rheum Dis 57 (1998) 275-280
33. Fonseca J.E., Lucas H., Canhao H., et al. Recommendations for the diagnosis and treatment of latent and active tuberculosis in inflammatory joint diseases candidates for therapy with tumor necrosis factor alpha inhibitors: March 2008 update. Acta Reumatol Port 33 (2008) 77-85
34. Rhodes H.L., Thomas P., Sporik R., et al. A birth cohort study of subjects at risk of atopy: Twenty-two-year follow-up of wheeze and atopic status. Am J Respir Crit Care Med 165 (2002) 176-180
35. Linneberg A., Gislum M., Johansen N., et al. Temporal trends of aeroallergen sensitization over twenty-five years. Clin Exp Allergy 37 (2007) 1137-1142
36. Wolkewitz M., Rothenbacher D., Low M., et al. Lifetime prevalence of self-reported atopic diseases in a population-based sample of elderly subjects: Results of the ESTHER study. Br J Dermatol 156 (2007) 693-697
37. Bousquet P.J., Chinn S., Janson C., et al. Geographical variation in the prevalence of positive skin tests to environmental aeroallergens in the European Community Respiratory Health Survey I. Allergy 62 (2007) 301-309
38. Asher M.I., Montefort S., Bjorksten B., et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 368 (2006) 733-743
39. Boissier M.C., Assier E., Falgarone G., et al. Shifting the imbalance from Th1/Th2 to Th17/treg: The changing rheumatoid arthritis paradigm. Joint Bone Spine 75 (2008) 373-375
40. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 13 (2007) 139-145
41. Rabin R.L., and Levinson A.I. The nexus between atopic disease and autoimmunity: A review of the epidemiological and mechanistic literature double dagger. Clin Exp Immunol (2008)